In yesterday’s Wall Street session, OptiNose Inc. (NASDAQ:OPTN) shares traded at $1.85, unchanged from the previous session.
5 analysts cover OptiNose Inc. (NASDAQ:OPTN), according to research data. The consensus rating among analysts is ‘Buy’. As we calculate the median target price by taking the range between a high of $8.00 and a low of $4.00, we find $5.00. Given the previous closing price of $1.85, this indicates a potential upside of 170.27 percent. OPTN stock price is now -46.05% away from the 50-day moving average and -38.17% away from the 200-day moving average. The market capitalization of the company currently stands at $190.64M.
The stock has received a hold rating from 0 analysts and a buy rating from 5. Brokers who have rated the stock have averaged $5.60 as their price target over the next twelve months.
, while ‘Cowen’ rates the stock as ‘Outperform’.
In other news, Miller Peter K, Chief Executive Officer sold 5,226 shares of the company’s stock on Sep 20. The stock was sold for $18,605 at an average price of $3.56. Upon completion of the transaction, the Chief Executive Officer now directly owns 887,451 shares in the company, valued at $1.64 million. An SEC document containing details of the transaction can be found on the SEC’s website. On Sep 20, Chief Commercial Officer Clavelli Victor M sold 832 shares of the business’s stock. A total of $2,962 was realized by selling the stock at an average price of $3.56. This leaves the insider owning 200,663 shares of the company worth $0.37 million. Insiders disposed of 247,425 shares of company stock worth roughly $0.46 million over the past 1 year. A total of 1.80% of the company’s stock is owned by insiders.
There have been several recent changes in the stakes of large investors in OPTN stock. A new stake in OptiNose Inc. shares was purchased by TWO SIGMA INVESTMENTS, LP during the first quarter worth $71,000. HIGHTOWER ADVISORS, LLC invested $56,000 in shares of OPTN during the first quarter. In the first quarter, SQUAREPOINT OPS LLC acquired a new stake in OptiNose Inc. valued at approximately $38,000. ARETE WEALTH ADVISORS, LLC acquired a new stake in OPTN for approximately $22,000. PSAGOT VALUE HOLDINGS LTD. / (ISRAEL) purchased a new stake in OPTN valued at around $10,000 in the second quarter.
During the past 12 months, OptiNose Inc. has had a low of $1.46 and a high of $4.30.
The net profit margin was -96.60% and return on equity was 150.00% for OPTN. The company reported revenue of $20.08 million for the quarter, compared to $21.83 million a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue fell -8.01 percent.